"Sleep Centers of Middle Tennessee provides medical care for the diagnosis and treatment of all known sleep disorders including sleep apnea, restless leg syndrome and insomnia."

During the past decade, Sleep Centers of Middle Tennessee conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sleep Centers of Middle Tennessee" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sleep Centers of Middle Tennessee" are "Obstructive Sleep Apnea" (2 trials). Many other conditions were trialed in "Sleep Centers of Middle Tennessee" in a lesser frequency.

Most popular intervention types in "Sleep Centers of Middle Tennessee" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Eclipse novel CPAP mask" (2 trials) and "Phillips Respironics Nuance" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sleep Centers of Middle Tennessee" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sleep Centers of Middle Tennessee". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sleep Centers of Middle Tennessee, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sleep Centers of Middle Tennessee, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".